<DOC>
	<DOC>NCT00441688</DOC>
	<brief_summary>This study is a cross sectional observational study to evaluate the prevalence of HLA-B*5701 in the major French ethnotypes. Any HIV-1 infected subject will be eligible for this study including antiretroviral therapy (ART) na√É-ve and experienced subjects irrespective of abacavir use, as well as subjects previously tested for HLA-B*5701. Subjects will be approached during a standard clinic visit, and all subjects will be consented prior to any study specific procedure. Subjects will be asked to provide a tissue sample (cheek cells and blood sample) which will be used to assess HLA-B*5701 status by central and local methodologies.</brief_summary>
	<brief_title>Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion criteria: HIV1 infected patients, ART naive or experienced over the age of 18 years. Patients must be either affiliated to or beneficiary of a social security category. Patient is willing and able to understand and provide written informed consent prior to participation in this study. Exclusion criteria:</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>HLAgenetics polymorphism</keyword>
	<keyword>Human Immunodeficiency virus</keyword>
</DOC>